16-3594566-C-T
Variant summary
Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS1
The NM_032444.4(SLX4):c.2047G>A(p.Ala683Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000148 in 1,614,056 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A683P) has been classified as Uncertain significance.
Frequency
Consequence
NM_032444.4 missense
Scores
Clinical Significance
Conservation
Publications
- Fanconi anemia complementation group PInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, G2P
- Fanconi anemiaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- familial ovarian cancerInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
- hereditary breast carcinomaInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -9 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000861 AC: 131AN: 152084Hom.: 1 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000219 AC: 55AN: 251298 AF XY: 0.000177 show subpopulations
GnomAD4 exome AF: 0.0000739 AC: 108AN: 1461854Hom.: 0 Cov.: 32 AF XY: 0.0000660 AC XY: 48AN XY: 727226 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000861 AC: 131AN: 152202Hom.: 1 Cov.: 32 AF XY: 0.000860 AC XY: 64AN XY: 74390 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Fanconi anemia Benign:2
- -
- -
not specified Uncertain:1
- -
not provided Uncertain:1
In silico analysis indicates that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -
Fanconi anemia complementation group P Benign:1
- -
SLX4-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at